Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
TIGIT expression dictates the immunosuppressive reprogramming of myeloid cells in glioblastoma.
Journal: Neuro-oncology
Published: May 05, 2025
Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma.
Journal: Cancers
Published: January 08, 2024
Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign.
Journal: Cancers
Published: December 13, 2022
A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma.
Journal: Cancer research communications
Published: November 01, 2022
Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors.
Journal: Cancer immunology, immunotherapy : CII
Published: September 17, 2022
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
Journal: Neuro-oncology advances
Published: June 06, 2022
The future of cancer immunotherapy for brain tumors: a collaborative workshop.
Journal: Journal of translational medicine
Published: March 07, 2022
Multiparametric MRI texture analysis in prediction of glioma biomarker status: added value of MR diffusion.
Journal: Neuro-oncology advances
Published: May 31, 2021
MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting.
Journal: International journal of molecular sciences
Published: September 15, 2020
The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
Journal: International journal of molecular sciences
Published: August 28, 2020
Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting.
Journal: International journal of molecular sciences
Published: May 25, 2020
Last Updated: 09/26/2026